CollPlant Biotechnologies (CLGN) Net Income towards Common Stockholders Growth (3y) (2020 - 2026)
CollPlant Biotechnologies (CLGN) Net Income towards Common Stockholders Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 45.47% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 38.43% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 13.80% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -3.84% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 91.31% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | -42.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2026 | -42.36% |
| Dec 31, 2025 | -5.62% |
| Sep 30, 2025 | 7.76% |
| Jun 30, 2025 | 40.26% |
| Mar 30, 2025 | -34.58% |
| Dec 31, 2024 | 51.02% |
| Sep 30, 2024 | -27.30% |
| Jun 30, 2024 | 51.50% |
| Mar 31, 2024 | -24.59% |
| Dec 31, 2023 | -68.87% |
| Sep 30, 2023 | -104.45% |
| Jun 30, 2023 | 70.82% |
| Mar 31, 2023 | 30.02% |
| Dec 31, 2022 | -52.15% |
| Sep 30, 2022 | -50.46% |
| Jun 30, 2022 | -55.31% |
| Mar 31, 2022 | 18.93% |
| Dec 31, 2021 | -510.72% |
| Sep 30, 2021 | 277.37% |
| Jun 30, 2021 | -59.44% |